|
|
视网膜静脉阻塞合并黄斑水肿治疗现状
|
Abstract:
视网膜静脉阻塞是多种原因导致视网膜静脉回流受阻，血液循环障碍的常见视网膜血管疾病，具有显著的致盲性。RVO根据阻塞的部位不同分为视网膜分支静脉阻塞(BRVO)、视网膜中央静脉阻塞(CRVO)。RVO患者视力下降的主要原因是黄斑水肿和新生血管。视网膜中央静脉研究小组(CVOS)提出格栅样激光光凝已经不是CRVO继发黄斑水肿(Macular Edema, ME)视力下降的一种有效的治疗方法。在过去的10几年中，几项主要的随机对照临床试验研究了RVO-ME新的治疗方法。本文旨在为RVO-ME的治疗提供现有的循证方法。
Retinal vein occlusions (RVO) are common retinal vascular disorders that have in common impaired venous return from the retinal circulation and blood circulation disorder, with the potential for significant vision-related morbidity. Retinal vein occlusions are classified as either branch retinal vein occlusion (BRVO) or central retinal vein occlusion (CRVO) based on the specific occlusion site. The main causes of vision loss in patients with RVO are associated with macular edema and neovascularization. The central vein occlusion study (CVOS) group demonstrated that grid laser photocoagulation is not an effective treatment for decreased vision due to CRVO-related macular edema. However, in the past ten years, several major randomized controlled clinical trials have investigated new therapeutic modalities for the treatment of macular edema secondary to RVO. This article aims to provide insight into current evidence based approaches to the treatment of RVO with macular edema.
| [1] | Scott, I.U., Van Veldhuisen, P.C., Ip, M.S., Blodi, B.A., Oden, N.L., Awh, C.C., et al. (2017) Effect of Bevacizumab vs Aflibercept on Visual Acuity among Patients with Macular Edema Due to Central Retinal Vein Occlusion: The SCORE2 Randomized Clinical Trial. JAMA, 317, 2072-2087. https://doi.org/10.1001/jama.2017.4568 |
| [2] | Ip, M. and Hendrick, A. (2018) Retinal Vein Occlusion Review. Asia-Pacific Journal of Ophthalmology (Philadelphia, Pa.), 7, 40-45. https://doi.org/10.22608/APO.2017163442 |
| [3] | Rogers, S., McIntosh, R.L., Journ, G.D., Lim, L., Wang, J.J., Mitchell, P., et al. (2010) The Prevalence of Retinal Vein of Clusion: Pooled Data from Population Studies from the United States, Europe, Asia, and Australia. Ophthalmology, 117, 313-319.E1. https://doi.org/10.1016/j.ophtha.2009.07.017 |
| [4] | Hayreh, S.S., Zimmerman, M.B. and Podhajsky, P. (1994) Incidence of Various Types of Retinal Vein Occlusion and Their Recurrence and Demographic Characteristics. American Journal of Ophthalmology, 117, 429-441.
https://doi.org/10.1016/S0002-9394(14)70001-7 |
| [5] | The Central Vein Occlusion Study Group (1997) Natural History and Clinical Management of Central Retinal Vein Occlusion. Archives of Ophthalmology, 115, 486-491. https://doi.org/10.1001/archopht.1997.01100150488006 |
| [6] | O’Mahoney, P.R., Wong, D.T. and Ray, J.G. (2008) Retinal Vein Occlusion and Traditional Risk Factors for Atherosclerosis. Archives of Ophthalmology, 126, 692-699. https://doi.org/10.1001/archopht.126.5.692 |
| [7] | Yen, Y.C., Weng, S.F., Chen, H.A. and Lin, Y.-S. (2013) Risk of Retinal Vein Occlusion in Patients with Systemic Lupus Erythematosus: A Population-Based Cohort Study. British Journal of Ophthalmology, 97, 1192-1196.
https://doi.org/10.1136/bjophthalmol-2013-303265 |
| [8] | The Eye Disease Case-Control Study Group (1993) Risk Factors for Branch Retinal Vein Occlusion. American Journal of Ophthalmology, 116, 286-296. https://doi.org/10.1016/S0002-9394(14)71345-5 |
| [9] | Eye Disease Case-Control Study Group (1996) Risk Factors for central Retinal Vein Occlusion. Archives of ophthalmology, 114, 545-554. https://doi.org/10.1001/archopht.1996.01100130537006 |
| [10] | Rath, E.Z., Frank, R.N., Shin, D.H. and Kim, C. (1992) Risk Factors for Retinal Vein Occlusions. A Case-Control Study. Ophthalmology, 99, 509-514. https://doi.org/10.1016/S0161-6420(92)31940-2 |
| [11] | Gunther, J., Scott, I.U. and Ip, M. (2008) Retinal Venous Occlusive Disease. In: Albert, D.M., Miller, J.W., Azar, D.T. and Blodi, B.A., Eds., Eds., Albert & Jakobiec’s Principles and Practice of Ophthalmology, 3rd Edition. Elsevier Inc., Philadelphia, 1755-1773. |
| [12] | Risard, S.M., Pieramici, D.J., Rabena, M.D., Basefsky, J.C., Avery, R.L., Castellarin, A.A., et al. (2011) Intravitreal Ranibizumab for Macular Edema Secondary to Central Retinal Vein Occlusion. Retina, 31, 1060-1067.
https://doi.org/10.1097/IAE.0b013e3181fbce76 |
| [13] | Ramchandran, R.S., Fekrat, S., Stinnett, S.S. and Jaffe, G.J. (2008) Fluocinolone Acetonide Sustained Drug Delivery Device for Chronic Central Retinal Vein Occlusion: 12-Month Results. American Journal of Ophthalmology, 146, 285-291.
https://doi.org/10.1016/j.ajo.2008.03.025 |
| [14] | Sun, C., Li, X.X., He, X.J., Zhang, Q. and Tao, Y. (2013) Neuroprotective Effect of Minocycline in a Rat Model of Branch Retinal Vein Occlusion. Experimental Eye Research, 113, 105-116. https://doi.org/10.1016/j.exer.2013.05.018 |
| [15] | Jovanovic, J., Liu, X., Kokona, D., Zinkernagel, M.S. and Ebneter, A. (2020) Inhibition of Inflammatory Cells Delays Retinal Degeneration in Experimental Retinal Vein Occlusion in Mice. Glia, 68, 574-588.
https://doi.org/10.1002/glia.23739 |
| [16] | Yafai, Y., Iandiev, I., Wiedemann, P., Reichenbach, A. and Eichler, W. (2004) Retinal Endothelial Angiogenic Activity: Effects of Hypoxia and Glial (Müller) Cells. Microcirculation, 11, 577-586.
https://doi.org/10.1080/10739680490503375 |
| [17] | Noma, H., Funatsu, H., Harino, S., Mimura, T., Eguchi, S. and Hori, S. (2011) Vitreous Inflammatory Factors in Macular Edema with Central Retinal Vein Occlusion. Japanese Journal of Ophthalmology, 55, 248-255.
https://doi.org/10.1007/s10384-011-0016-4 |
| [18] | Noma, H., Mimura, T. and Eguchi, S. (2013) Association of Inflammatory Factors with Macular Edema in Branch Retinal Vein Occlusion. JAMA Ophthalmology, 131, 160-165. https://doi.org/10.1001/2013.jamaophthalmol.228 |
| [19] | Suzuki, Y., Nakazawa, M., Suzuki, K., Yamazaki, H. and Miyagawa, Y. (2011) Expression Profiles of Cytokines and Chemokines in Vitreous Fluid in Diabetic Retinopathy and Central Retinal Vein Occlusion. Japanese Journal of Ophthalmology, 55, 256-263. https://doi.org/10.1007/s10384-011-0004-8 |
| [20] | 韩丹. 中青年人和老年人视网膜中央静脉阻塞前房水中VEGF、IL-6和IL-8因子水平的临床研究[D]: [硕士学位论文]. 石家庄: 河北医科大学, 2018: 1-35. |
| [21] | Noma, H., Funatsu, H., Mimura, T., Harino, S. and Hori, S. (2009) Vitreous Levels of Interleukin-6 and Vascular Endothelial Growth Factor in Macular Edema with Central Retinal Vein Occlusion. Ophthalmology, 116, 87-93.
https://doi.org/10.1016/j.ophtha.2008.09.034 |
| [22] | The Central Vein Occlusion Study Group (1995) Evaluation of Grid Pattern Photocoagulation for Macular Edema in Central Vein Occlusion. The Central Vein Occlusion Study Group M Report. Ophthalmology, 102, 1425-1433. |
| [23] | Branch Vein Occlusion Study Group (1986) Argon Laser Scatter Photocoagulation for Prevention of Neovascularization and Vitreous Hemorrhage in Branch Vein Occlusion. A Randomized Clinical Trial. Archives of ophthalmology, 104, 34-41. https://doi.org/10.1001/archopht.1986.01050130044017 |
| [24] | Campochiaro, P.A., Hafiz, G., Mir, T.A., Scott, A.W., Solomon, S., Zimmer-Galler, I., et al. (2015) Scatter Photocoagulation Does Not Reduce Macular Edema or Treatment Burden in Patients with Retinal Vein Occlusion: The RELATE Trial. Ophthalmology, 122, 1426-1437. https://doi.org/10.1016/j.ophtha.2015.04.006 |
| [25] | Wykoff, C.C., Ou, W.C., Wang, R., Brown, D.M., Cone, C., Zamora, D., et al. (2017) Peripheral Laser for Recalcitrant Macular Edema Owing to Retinal Vein Occlusion: The WAVE Trial. Ophthalmology, 124, 919-921.
https://doi.org/10.1016/j.ophtha.2017.01.049 |
| [26] | Funk, M., Kriechbaum, K., Prager, F., Benesch, T., Georgopoulos, M., Zlabinger, G.J., et al. (2009) Intraocular Concentrations of Growth Factors and Cytokines in Retinal Vein Occlusion and the Effect of Therapy with Bevacizumab. Investigative Ophthalmology & Visual Science, 50, 1025-1032. https://doi.org/10.1167/iovs.08-2510 |
| [27] | Brown, D.M., Campochiaro, P.A., Singh, R.P., Li, Z., Gray, S., Saroj, N., et al. (2010) Ranibizumab for Macular Edema Following Central Retinal Vein Occlusion: Six-Month Primary End Point Results of a Phase III Study. Ophthalmology, 117, 1124-1133.e1. https://doi.org/10.1016/j.ophtha.2010.02.022 |
| [28] | Heier, J.S., Campochiaro, P.A., Yau, L., L,i Z., Saroj, N., Rubio, R.G., et al. (2012) Ranibizumab for Macular Edema Due to Retinal Vein Occlusions: Long-Term Follow-Up in the HORIZON Trial. Ophthalmology, 119, 802-809.
https://doi.org/10.1016/j.ophtha.2011.12.005 |
| [29] | Campochiaro, P.A., Clark, W.L., Boyer, D.S., Heier, J.S., Brown, D.M., Vitti, R., et al. (2015) Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion: The 24-Week Results of the VIBRANT Study. Ophthalmology, 122, 538-544. https://doi.org/10.1016/j.ophtha.2014.08.031 |
| [30] | Heier, J.S., Clark, W.L., Boyer, D.S., Brown, D.M., Vitti, R., Berliner, A.J., et al. (2014) Intravitreal Aflibercept Injection for Macular Edema Due to Central Retinal Vein Occlusion: Two-Year Results from the COPERNICUS Study. Ophthalmology, 121, 1414-1420.e1. https://doi.org/10.1016/j.ophtha.2014.01.027 |
| [31] | Ogura, Y., Roider, J., Korobelnik, J.F., Holz, F.G., Simader, C., Schmidt-Erfurth, U., et al. (2014) Intravitreal Aflibercept for Macular Edema Secondary to Central Retinal Vein Occlusion: 18-Month Results of the Phase 3 GALILEO Study. American Journal of Ophthalmology, 158, 1032-1038.E2. https://doi.org/10.1016/j.ajo.2014.07.027 |
| [32] | 吴香瑞, 梁凤鸣, 宋帅. 联合方案治疗BRVO-ME远期疗效的Meta分析[J]. 国际眼科杂志, 2021, 21(1): 92-98.
https://doi.org/10.3980/j.issn.1672-5123.2021.1.19 |
| [33] | Schmidt-Erfurth, U., Garcia-Arumi, J., Gerendas, B.S., Midena, E., Sivaprasad, S., Tadayoni, R., et al. (2019) Guidelines for the Management of Retinal Vein Occlusion by the European Society of Retina Specialists (EURETINA). Ophthalmologica, 242, 123-162. https://doi.org/10.1159/000502041 |
| [34] | Scott, I.U., Ip, M.S., VanVeldhuisen, P.C., Oden, N.L., Blodi, B.A., Fisher, M., et al. (2009) A Randomized Trial Comparing the Efficacy and Safety of Intravitreal Triamcinolone with Standard Care to Treat Vision Loss Associated with Macular Edema Secondary to Branch Retinal Vein Occlusion: The Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study Report 6. Archives of ophthalmology, 127, 1115-1128.
https://doi.org/10.1001/archophthalmol.2009.233 |
| [35] | Haller, J.A., Bandello, F., Belfort Jr., R., Blumenkranz, M.S., Gillies, M., Heier, J., et al. (2010) Randomized, Sham- Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Macular Edema Due to Retinal Vein Occlusion. Ophthalmology, 117, 1134-1146.e3. https://doi.org/10.1016/j.ophtha.2010.03.032 |
| [36] | Haller, J.A., Bandello, F., Belfort Jr., R., Blumenkranz, M.S., Gillies, M., Heier, J., et al. (2011) Dexamethasone Intravitreal Implant in Patients with Macular Edema Related to Branch or Central Retinal Vein Occlusion: Twelve-Month Study Results. Ophthalmology, 118, 2453-2460. https://doi.org/10.1016/j.ophtha.2011.05.014 |
| [37] | Singer, M.A., Jansen, M.E., Tyler, L., Woods, P., Ansari, F., Jain, U., et al. (2016) Long-Term Results of combination Therapy Using Anti-VEGF Agents and Dexamethasone Intravitreal Implant for Retinal Vein Occlusion: An Investigational Case Series. Clinical Ophthalmology, 11, 31-38. https://doi.org/10.2147/OPTH.S119373 |
| [38] | Mayer, W.J., Remy, M., Wolf, A., Kook, D., Kampik, A., Ulbig, M., et al. (2012) Comparison of Intravitreal Bevacizumab Upload Followed by a Dexamethasone Implant versus Dexamethasone Implant Monotherapy for Retinal Vein Occlusion with Macular Edema. Ophthalmologica, 228, 110-116. https://doi.org/10.1159/000338732 |
| [39] | 郝壮, 王珏, 冀帅飞, 张婕. 抗VEGF 药物联合皮质类固醇激素治疗视网膜静脉阻塞性黄斑水肿的Meta分析[J]. 国际眼科杂志, 2021, 21(1): 99-105. |
